+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Transgenic expression of human kallikrein prevents sarcoplasmic reticular calcium ion transport dysfunction in diabetic rat heart



Transgenic expression of human kallikrein prevents sarcoplasmic reticular calcium ion transport dysfunction in diabetic rat heart



Hypertension 36(4): 655




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035974128

Download citation: RISBibTeXText


Related references

Prevention of sarcoplasmic reticular Ca transport dysfunction in diabetic heart with transgenic human kallikrein expression is not due to altered SERCA2 and phospholamban expression. Naunyn-Schmiedeberg's Archives of Pharmacology 362(4-5 Supplement): R29, 2000

Transgenic expression of human kallikrein prevents haemodynamic alterations and decline in sarcoplasmic reticulum calcium pump activity in diabetic rats. European Heart Journal 21(Abstract Supplement): 3, August-September, 2000

Transgenic expression of human kallikrein prevents altered left ventricular function, the decline in sarcoplasmic reticulum calcium pump activity and the rise in cardiac collagen content in diabetic rats. Circulation 102(18 Supplement): II 267, October 31, 2000

Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene. Faseb Journal 18(15): 1967-1969, 2004

Transgenic expression of kallikrein prevents left ventricular dysfunction and inhibits endothelial induction of ICAM-1 and intramyocardial LFA-1/Mac-1+ infiltration in streptozotocin-induced diabetic cardiopathy in rats. Circulation 104(17 Supplement): II 198, October 23, 2001

Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. American Journal of Physiology 244(6): E528-E535, 1983

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. Faseb Journal 18(7): 828-835, 2004

Transgenic activation of the kallikrein-kinin system prevents streptozotocin-diabetic hearts from cardiac fibrosis and left ventricular dysfunction. European Heart Journal 22(Abstract Supplement): 54, 2001

Effect of calmodulin on sarcoplasmic reticular sr calcium transport in the aging heart. Journal Of Molecular & Cellular Cardiologyppl. 3: S18, 1988

Effect of calmodulin on sarcoplasmic reticular calcium transport in the aging heart. Molecular & Cellular Biochemistry 85(1): 75-80, 1989

Transgenic expression of kallikrein prevents from diabetic cardiomyopathy by inhibition of ICAM-1 induction and infiltration. European Heart Journal 23(Abstract Supplement): 205, August-September, 2002

Cardiac reticular Ca transport and contractility of papillary muscle of transgenic rats overexpressing the sarcoplasmic reticular Ca ATPase SERCA2. Naunyn-Schmiedeberg's Archives of Pharmacology 362(4-5 Supplement): R29, 2000

Total adenine nucleotide stores and sarcoplasmic reticular calcium transport in ischemic rat heart. American Journal of Physiology 247(3 PART 2): H380-H386, 1984

Depressed sarcoplasmic reticular calcium transport in congestive heart failure secondary to myocardial infarction. Journal of Molecular & Cellular Cardiology 21(SUPPL 2): S49, 1989

Effects of simvastatin on cardiac performance and expression of sarcoplasmic reticular calcium regulatory proteins in rat heart. Acta Pharmacologica Sinica 26(6): 696-704, 2005